OPKO Health, Inc.
OPKHealthcareNASDAQDiagnostics & Research · Last scanned Jul 18, 2026
Scan Results
Daily timeframeOPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. Valued at $898.6M, OPK is a small-cap name in its sector. The company operates in two segments, Pharmaceutical and Diagnostics.
Market Cap
$898.6M
Beta
1.48
P/E (TTM)
—
P/E (Fwd)
-3.72
EPS (TTM)
$-0.27
EPS (Fwd)
$-0.32
ROE
-16.9%
ROA
-6.4%
Cash
$331.9M
Total Debt
$396.9M
Free CF
-$36.1M
52W Change
-11.8%
Annual Financials
Cash vs Debt
On the balance sheet, OPK has $331.9M in cash with $396.9M in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow is running at -$36.1M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. Return on equity stands at -16.9%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has pulled back from $1.00B (2022) to $606.9M (2025), a 40% decline worth watching.
The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing OPK.